Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Pardoel, Soesja
DOB:	13-DEC-1961 (Age: 63)
Gender:	female
Address:	Eemnesserweg 107 1251 NA Laren (Netherlands)
ID:	3706-987673-0

Report
Date:	30-MAY-2025

Laboratory

Requested by
Gezondheidscentrum Vizier 1315 Almere-Stad (Netherlands)

Specimen
Collected:	29-MAY-2025

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Hematology

Test	29 May 2025	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	0.9 L	3.6 - 10.5	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	4.1	3.9 - 5.2	10*6/uL
Hemoglobin [Mass/volume] in Blood	7.8 L	12 - 16	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	27.9 L	37 - 45	%
MCV [Entitic volume] by Automated count	91.5	80 - 99	fL
MCH [Entitic mass] by Automated count	30.6	27 - 34	pg
MCHC [Mass/volume] by Automated count	33.6	31 - 35	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	39.1	36 - 46	fL
Platelets [#/volume] in Blood by Automated count	447.0	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	350.1	150 - 450	fL
Platelet mean volume [Entitic volume] in Blood by Automated count	11.4	9.4 - 14	fL

Chemistry

Test	29 May 2025	Reference Range	Unit
Glucose [Mass/volume] in Blood	94.2	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	17.6	7 - 43	mg/dL
Creatinine [Mass/volume] in Blood	2.7 H	0.5 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.5	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	141.5	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	5.0	3.5 - 5.3	mmol/L
Chloride [Moles/volume] in Blood	106.9 H	98 - 106	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	22.0	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	6.9	6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	3.6	3.4 - 5	g/dL
Globulin [Mass/volume] in Serum by calculation	2.2	2 - 3.5	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.9	0.3 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	54.2	39 - 141	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	29.1	7 - 33	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	31.8	10 - 40	U/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated creatinine, indicating impaired renal function, and mild hyperchloremia. There is marked anemia (low hemoglobin and hematocrit) and significant leukopenia, suggesting possible bone marrow suppression or chronic disease. Electrolytes, liver enzymes, and protein levels are within normal limits. Glucose is now normal but was previously low. Recommend further evaluation of renal function, anemia, and leukopenia, and clinical correlation for underlying causes.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistently elevated creatinine, indicating impaired renal function, and mild hyperchloremia. There is marked anemia (low hemoglobin and hematocrit) and significant leukopenia, suggesting possible bone marrow suppression or chronic disease. Electrolytes, liver enzymes, and protein levels are within normal limits. Glucose is now normal but was previously low. Recommend further evaluation of renal function, anemia, and leukopenia, and clinical correlation for underlying causes.